Who owns IN8BIO INC?

Tip: Access positions for across all investors

Analyze quarterly positions in In8bio with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of In8bio stock

Who bought or sold IN8BIO INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
AIGH Capital Management 2.9M $3.4M -30% Mar 2024
 View chart
Vanguard Group 1.4M $1.7M 242% Mar 2024
 View chart
Ensign Peak Advisors 1.1M $1.3M 138% Mar 2024
 View chart
683 Capital Management 615k $725k 0% Mar 2024
 View chart
Sigma Planning 515k $608k 290% Mar 2024
 View chart
Alyeska Investment Group 446k $526k -73% Mar 2024
 View chart
Voss Capital 341k $471k -33% Dec 2023
 View chart
Geode Capital Management 281k $331k 49% Mar 2024
 View chart
Stonegate Investment Group 180k $212k 0% Mar 2024
 View chart
Rock Creek Group 151k $209k 0% Mar 2024
 View chart
Bridgeway Capital Management 103k $122k 32% Mar 2024
 View chart
Texas Capital Bank Wealth Management Services 79k $93k 0% Mar 2024
 View chart
Northern Trust 49k $58k 13% Mar 2024
 View chart
Laird Norton Tyee Trust 42k $50k 100% Mar 2024
 View chart
Two Sigma Investments 42k $49k -2% Mar 2024
 View chart
Overbrook Management Corp. 34k $40k 0% Mar 2024
 View chart
Millennium Management 33k $38k 100% Mar 2024
 View chart
BlackRock 28k $33k -5% Mar 2024
 View chart
Wela Strategies 19k $22k 100% Mar 2024
 View chart
Two Sigma Securities 18k $21k 100% Mar 2024
 View chart
Virtu Financial 14k $17k 100% Mar 2024
 View chart
Charles Schwab Investment Management 13k $16k 0% Mar 2024
 View chart
Westside Investment Management 12k $14k -17% Mar 2024
 View chart
Goldman Sachs Group 12k $14k 100% Mar 2024
 View chart
Tower Research Capital 11k $13k -7% Mar 2024
 View chart
Vontobel Holding 10k $12k 0% Mar 2024
 View chart
Wells Fargo & Company 247.00 $290.990700 56% Mar 2024
 View chart
Jpmorgan Chase & Co 69.00 $80.999100 103% Mar 2024
 View chart
Royal Bank of Canada 47.00 $0 -82% Mar 2024
 View chart

Who sold out of In8bio?

Fund or Company Name Date Sold Shares Held Valued At
Citadel Advisors Dec 2023 20k $27k
HighTower Advisors Dec 2023 10k $14k
UBS Group Dec 2023 4.5k $6.2k